Carbapenem-resistant Acinetobacter baumannii is a major health problem worldwide, especially in intensive care units (ICUs). This study aimed to detect the prevalence of A. baumannii colonization of the gastrointestinal tract of patients admitted to the ICU in two hospitals in Saudi Arabia. In addition, it aimed to characterize the molecular mechanisms of carbapenem resistance in these isolates. From January to June 2014, 565 rectal swab specimens were screened for Acinetobacer strains and carbapenem resistance using CHROMagar Acinetobacter and CHROMagar KPC agar plates, respectively. Organism identification and susceptibility were detected using the Vitek 2 system. A total of 47 Acinetobacter spp. were detected, and 35 were resistant to carbapenem, making the prevalence of Acinetobacter spp. 8.3 % (47/565) and carbapenem resistance (6.2 %, 35/565). The 47 strains showed remarkable clonal diversity as revealed by PFGE. Using PCR, OXA-51, a chromosomal marker for A. baumannii, was detected in 46 strains. OXA-23 b-lactamase was detected in all 35 carbapenem-resistant A. baumannii. No IMP, VIM, SPM, SIM, GIM, KPC or NDM b-lactamases were detected in these isolates. Thus, OXA-23 was the main mechanism of carbapenem resistance in these isolates. To the best of our knowledge, this is the first study to detect the prevalence of Acinetobacter colonization in the digestive tract of ICU patients in Saudi Arabia. This study revealed the importance of having wellestablished protocols for early identification of these multidrug-resistant organisms, optimizing infection-control strategies and having active surveillance studies to reduce morbidity, mortality and cost.
INTRODUCTION
Acinetobacter baumannii has emerged as a leading cause of nosocomial infections, especially in intensive care units (ICUs), causing a variety of infections including septicaemia, urinary tract infections and wound infections (Maragakis & Perl, 2008; Peleg et al., 2008; Poirel & Nordmann, 2006) . It is a leading cause of ventilator-associated pneumonia worldwide (Maragakis & Perl, 2008; Mugnier et al., 2008; Peleg et al., 2008) . From 2005 to 2009, A. baumannii caused approximately 26.5 % of ventilator-associated pneumonia in Riyadh, Saudi Arabia (El-Saed et al., 2013) . The prevalence of carbapenem-resistant A. baumannii (CRAB) has increased worldwide including countries of the Gulf Cooperation Council such as Kuwait, Saudi Arabia and Bahrain (Abdalhamid et al., 2014; Al-Sweih et al., 2012; Alsultan et al., 2014; ElSaed et al., 2013; Khan et al., 2012; Mugnier et al., 2008) .
Carbapenem resistance in A. baumannii is due mainly to the production of carbapenem-hydrolysing enzymes, carbapenemases (Maragakis & Perl, 2008; Peleg et al., 2008; Poirel & Nordmann, 2006) . Carbapenemases include class A Klebsiella pneumonia carbapenemases (KPCs), class B (metallo-b-lactamases) such as IMP, VIM and NDM blactamases, and class D oxacillinases (OXAs). OXA-type carbapenemases have been divided into eight subgroups of which OXA-23-like, OXA-24-like, OXA-51-like and OXA-58-like have been described in A. baumannii. The group of OXA-51 has been detected chromosomally and is used typically as a marker for A. baumannii. These enzymes are commonly encoded on mobile DNA elements such as plasmid, integrons and insertion sequences, and can easily spread from organism to organism and from patient to patient creating major infection-control problems (Maragakis & Perl, 2008; Poirel & Nordmann, 2006; Woodford et al., 2006) . The ISAba1 element, a member of the IS4 family, has been detected upstream of OXA-23 and OXA-51 causing gene overexpression, which results in carbapenem resistance (Abdalhamid et al., 2014; Segal et al., 2005; Turton et al., 2006) .
Despite several measures of infection control having been implemented including hand hygiene, patient isolation and environmental decontamination, A. baumannii remains an ongoing problem in many health institutes all over the world associated with increased rates of morbidity and mortality (Corbella et al., 1996; Dijkshoorn et al., 2005; Doi et al., 2011; Gordon & Wareham, 2009; Jung et al., 2010) . Several studies have reported high rates of faecal carriage of Acinetobacter, especially in ICU patients, making the digestive tract a reservoir for nosocomial infections and outbreaks caused by Acinetobacter spp., especially multidrug-resistant Acinetobacter isolates (Corbella et al., 1996; Dijkshoorn et al., 2005; Doi et al., 2011; Gordon & Wareham, 2009; Jung et al., 2010) . In order to control the spread and outbreaks caused by such organisms, rectal swab screening to detect patient colonization with CRAB has been suggested by several studies using a number of screening methods such as CHROMagar Acinetobacter (Corbella et al., 1996; Dijkshoorn et al., 2005; Gordon & Wareham, 2009) . In addition, different carbapenem resistance screening CHROMagar media (CHROMagar KPC, chromID-CARBA, Brilliance CRE and SUPERCARBA) have been also used with variable success (Girlich et al., 2013; Gordon & Wareham, 2009; Vrioni et al., 2012) . In Saudi Arabia, there have been few studies determining the prevalence of Acinetobacter spp. colonization and/or infections and characterizing the molecular mechanisms of carbapenem resistance (Abdalhamid et al., 2014; Alsultan et al., 2014; El-Saed et al., 2013) .
The aim of this study was to evaluate the prevalence of colonization and carbapenem resistance in Acinetobacter spp. isolated from the intestinal microbiota of ICU patients at two hospitals in the Eastern Province of Saudi Arabia. In addition, we also aimed to characterize the molecular mechanisms of carbapenem resistance in these Acinetobacter isolates.
METHODS
Setting and study population. This study was conducted in a 650-bed tertiary care hospital, King Fahad Specialist Hospital-Dammam, and a 450-bed general hospital, King Fahad University Hospital, Dammam University, Khobar, in the Eastern Province of Saudi Arabia. From January to June 2014, non-repetitive rectal swab specimens from patients admitted to the ICUs in both hospitals were collected and screened for Acinetobacter spp. and CRAB using CHROMagar Acinetobacter and CHROMagar KPC, respectively, as recommended by the manufacturer (CHROMagar).
Organism identification and antimicrobial susceptibility testing. Red and/or creamy opaque colonies growing on CHROMagar Acinetobacter and/or CHROMagar KPC, respectively, were subcultured on sheep blood agar and MacConkey agar plates for identification and antimicrobial susceptibility testing using the Vitek 2 automatic system (bioMérieux) according to the manufacturer's recommendations. Clinical and Laboratory Standards Institute (CLSI) recommendations were used to determine MICs and breakpoints. The controls for the antimicrobial susceptibility testing were Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853.
PCR and sequencing of carbapenemase genes. All Acinetobacter strains were analysed for carbapenemase genes using PCR protocols for genes encoding IMP, VIM, SIM, SPM, GIM, KPC, NDM blactamases, as published in the literature (Chihara et al., 2011; Gröbner et al., 2009; Mendes et al., 2007; Woodford et al., 2006) . In addition, multiplex PCR was performed to detect OXA carbapenemases (OXA-23, OXA-24 and OXA-58) as described previously (Woodford et al., 2006) . A PCR using primers for OXA-51 was performed to detect the chromosomally encoded OXA-51, which was used as a marker to identify A. baumannii. The full-length gene of OXA-23 was sequenced using an ABI 3730xl DNA analyser (Applied Biosystems) using flanking primers for the corresponding genes, as described previously (Abdalhamid et al., 2014) . A. baumannii strains harbouring OXA-51 only were tested by PCR for the ISAba1 element as described previously (Turton et al., 2006) . Positive controls for the genes described above were used in the PCR protocols, and molecular-grade water was used as a negative control. The primers used in this study (Chihara et al., 2011; Gröbner et al., 2009; Mendes et al., 2007; Woodford et al., 2006) are listed in Table 1 .
Clonal analysis for A. baumannii clinical strains. Total chromosomal DNA from the A. baumannii isolates was prepared, digested using ApaI enzyme and analysed for genotypic relatedness using PFGE as described previously (Bannerman et al., 1995) . A CHEF-DR II apparatus (Bio-Rad Laboratories) was used with the following parameters: 200 V for 22 h at 14 uC, with a ramped pulse of 5-13 s. Gels were stained with ethidium bromide, destained in distilled water and analysed using a Quantity One Gel Doc software photograph. The ratio of infected patients to clones was used to estimate the clonal dissemination index (CDI).
Statistical analysis. Fisher's exact test was used to compare categorical variables where P,0.05 was considered statistically significant.
RESULTS
During a 6-month period, 565 rectal swab specimens were screened. A total of 47 Acinetobacter spp. isolates were detected and confirmed using the Vitek 2 system ( Table 2 ). The prevalence of Acinetobacter colonization of patients admitted to the ICU was 8.3 % (47/565). A total of 35 strains out of 47 Acinetobacter strains were carbapenem resistant by CHROMagar KPC and Vitek 2, and therefore the prevalence of CRAB isolates was 6.2 % (35/565). A total of 46 strains harboured the chromosomally encoded OXA-51 and were identified as A. baumannii, whilst one strain was negative for OXA-51 and was identified as Acinetobacter sp. other than A. baumannii (Table 2 ).
PFGE data revealed that a total of 41 clones were detected among the 47 Acinetobacter isolates. The CDI did not statistically significantly exceed a value of 1.
According to the Vitek 2 data, all strains were susceptible to colistin. A total of 12 strains were susceptible to carbapenems including the Acinetobacter sp. that was not an A. baumannii strain. These carbapenem-susceptible Acinetobacter strains were also susceptible to amikacin, gentamicin, tigecycline, cefepime and ciprofloxacin. A total of 35 strains were resistant to carbapenem (74.5 %, 35/47). All 35 CRAB isolates were resistant to cefepime and ciprofloxacin, whilst 22 and 14 of these strains were resistant to gentamicin and amikacin, respectively (Tables 2 and 3 ). In addition, 17 CRAB isolates were resistant to tigecycline. Therefore, the overall susceptibility rates in the Acinetobacter isolates were 100 % for colistin, 70.2 % for amikacin, 63.8 % for tigecycline, 53.2 % for gentamicin and 25.5 % for ciprofloxacin and cefepime (Table 3 ).
The CRAB isolates were significantly (P,0.05) more resistant to cefepime, amikacin, gentamicin, tigecycline and ciprofloxacin in comparison with the carbapenem-susceptible Acinetobacter strains. However, the CRAB isolates were also more resistant, but not significantly so, than the carbapenem-susceptible ones (P.0.05) to colistin (Table 3) .
A PCR amplicon of 501 bp correlating to OXA-23 was detected in all CRAB isolates and was confirmed by sequencing the full-length PCR product (822 bp) as OXA-23. As mentioned above, all strains except one encoded OXA-51. No ISAba1 element was detected upstream of OXA-51 in any of the 12 carbapenem-susceptible A. baumannii isolates. PCR screening did not detect genes for IMP, VIM, SIM, SPM, NDM, KPC or GIM b-lactamases. In the present study, the prevalence of Acinetobacter colonization in the ICUs was 8.3 % and the prevalence of CRAB isolates was 6.2 %. To the best of our knowledge, this is the first report on the prevalence of A. baumannii colonization and carbapenem resistance in patients admitted to ICUs in Saudi Arabia. The faecal carriage rates were 12.6 and 41 % in studies conducted in the Republic of Korea and Spain, respectively (Corbella et al., 1996; Huang et al., 2013) , which were higher than the rate in our study. It is necessary to conduct more studies to estimate the faecal carriage rates of Acinetobacter in Saudi Arabia, as several investigations have revealed that colonization is significantly associated with nosocomial infections (Huang et al., 2013; Jung et al., 2010) . According to Jung et al. (2010) , 54 % (108/200) of the ICU patients colonized with multidrug-resistant A. baumannii developed infections in et al., 2010) . These findings raise a critical question of whether antibiotic therapy should be given to the colonized patients or whether the introduction of infection-control The PFGE data revealed that a total of 41 clones were detected among the 47 Acinetobacter isolates with low CDI values. These results represent a wide range of clonal diversity, which is to be expected for several reasons. First, the study was conducted in two different hospitals; one hospital is general and the other is tertiary. Secondly, no hospital outbreaks by A. baumannii were reported from the two hospitals during the period of study, and all environmental samples routinely collected to detect outbreaks caused by multidrug-resistant A. baumannii were negative during that time. All these patients were colonized by A. baumannii upon ICU admission, suggesting that the colonization was community acquired and not nosocomial. These data also suggest that the transmission of Acinetobacter from one hospital to another was insignificant.
Although the prevalence of CRAB isolated was low (6.2 %) in the screened patients, the resistance rate was high (74.5 %) among the A. baumannii strains. These data were in correlation with data published from other institutes in Saudi Arabia and this region, such as the United Arab Emirates, Kuwait, Turkey, Bahrain, Iran and Qatar (Abdalhamid et al., 2014; Al-Sweih et al., 2012; Alsultan et al., 2014; Feizabadi et al., 2008; Gur et al., 2008; Khan et al., 2012; Mugnier et al., 2008 Mugnier et al., , 2009 ). Genetic analysis revealed that OXA-23 was detected in all CRAB isolates, and therefore OXA-23 is the main mechanism of carbapenem resistance in these isolates. These data are concordant with data published in Saudi Arabia, the Gulf region, Egypt and Iran (Al-Agamy et al., 2014; El-Saed et al., 2013; Feizabadi et al., 2008; Mugnier et al., 2009) . In addition, OXA-23-producing A. baumannii isolates have caused several outbreaks worldwide such as in Turkey, Brazil, Korea, Tunisia and Italy (Dalla-Costa et al., 2003; Gur et al., 2008; Jeon et al., 2005; Mansour et al., 2008; Principe et al., 2014) . It is important to note that OXA-23 is not the only mechanism causing carbapenem resistance in A. baumannii. In a study conducted in Kuwait, IMP-1 and VIM-2 metallo-b-lactamses were the main resistance mechanism in CRAB isolates (Al-Sweih et al., 2012) . In addition, OXA-40 was detected in Saudi Arabia and Bahrain, as well as in studies published from the USA and Europe (Alsultan et al., 2014; Lopez-Otsoa et al., 2002; Peleg et al., 2008; Tian et al., 2011) . It is unlikely that OXA-51 has contributed to carbapenem resistance, as it is an intrinsically chromosomally encoded element without ISAba1, being encoded upstream of it. In addition, the 11 A. baumannii strains encoding only OXA-51 were susceptible to carbapenem.
No gene amplification for IMP, VIM, SIM, SPM, NDM, KPC or GIM b-lactamases was detected by PCR using genespecific primers. Other studies from this region correlate with our study, as KPC, NDM, SIM and GIM have not been reported previously. SPM has been reported only in Saudi Arabia and Iran (Alsultan et al., 2014; Mohajeri et al., 2013) . IMP and VIM have been reported in only one study in the region (Al-Sweih et al., 2012) .
Carbepenem resistance in CRAB isolates was significantly associated with resistance to other antimicrobial agents including cefepime, ciprofloxacin, gentamicin, amikacin and tigecycline compared with carbapenem-susceptible A. baumannii strains. These data are concordant with data published in Saudi Arabia, the Gulf region, Turkey and Iran (Abdalhamid et al., 2014; Al-Sweih et al., 2012; Gur et al., 2008; Khan et al., 2012; Mohajeri et al., 2013) . The susceptibility rate to colistin was 100 %, which correlates with other reports published in Saudi Arabia and Iran. However, resistance to colistin has also been reported in several publications from Saudi Arabia, the Gulf region and Iran (Alsultan et al., 2014) . This increase in colistin resistance is alarming, because colistin is the last resort that physicians have to treat CRAB isolates.
In summary, to the best of our knowledge, this is the first study to detect the prevalence of carbapenem-resistant A. baumannii colonization in the digestive tract of patients admitted to ICUs in Saudi Arabia. This study revealed that OXA-23 is the dominant molecular mechanism of carbapenem resistance in these isolates. The data also revealed the importance of implementing good infection-control strategies and active planning to detect CRAB colonizers to 
